| Tara Boyd, ATC | |
|
150 Pap Paw Pl, Austin, AR 72007-9020 | |
| (501) 259-3439 | |
| Not Available |
| Full Name | Tara Boyd |
|---|---|
| Gender | Female |
| Speciality | Specialist/technologist - Athletic Trainer |
| Location | 150 Pap Paw Pl, Austin, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457898314 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Tara Boyd, ATC 150 Pap Paw Pl, Austin, AR 72007-9020 Ph: (501) 259-3439 | Tara Boyd, ATC 150 Pap Paw Pl, Austin, AR 72007-9020 Ph: (501) 259-3439 |
News Archive
It starts with a headache, chills or that all-over-achy feeling. It comes on quickly, yet too many Canadians ignore the rapid onset of flu symptoms. But for the millions of Canadians at increased risk for developing serious complications from the flu, including people 65 and older, pregnant women and those with chronic medical conditions like chronic obstructive pulmonary disease (COPD), asthma, heart disease and diabetes, this 'laissez faire' attitude could be putting their health in jeopardy.
Providing early, appropriate antibiotic treatment for patients with sepsis — serious complication of infection that can lead to organ failure and death — is crucial for their survival.
Eating a hot dog could cost you 36 minutes of healthy life, while choosing to eat a serving of nuts instead could help you gain 26 minutes of extra healthy life, according to a University of Michigan study.
A final analysis of the Phase 3 COU-AA-302 trial presented today at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid, Spain showed that ZYTIGA® (abiraterone acetate) plus prednisone significantly prolonged overall survival (OS), compared to an active control of placebo plus prednisone, in men with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
A new study, published in the Journal of Regulatory Toxicology and Pharmacology, found that e-cigarettes share a similar short-term safety profile as Nicorette products and are comparable in reducing tobacco withdrawal symptoms.
› Verified 9 days ago